Cargando…
Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features
Two patients presented simultaneously to our hospital with distinct clinical features associated with the presence of anti-MDA5 antibodies: the first one was admitted for a skin rash resembling to a toxic epidermal necrosis (Lyell syndrome) and the second one presented with pulmonary manifestations...
Autores principales: | Pacot, Laurence, Pouchot, Jacques, De Prost, Nicolas, Senant, Marie, Tartour, Eric, Le Pimpec-Barthes, Françoise, Israel-Biet, Dominique, Dragon-Durey, Marie-Agnes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076087/ https://www.ncbi.nlm.nih.gov/pubmed/32211415 http://dx.doi.org/10.3389/fmed.2020.00077 |
Ejemplares similares
-
Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017) -
Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022) -
Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015) -
Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020) -
Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)